Kisspeptin 10mg Pre-Mixed Stabilized Pen

Description

Kisspeptin 10MG, a ten-amino acid piece derived from the kisspeptin protein, is now a focal point in reproductive and peptide studies.

This peptide is valuable in puberty, fertility, and hormone studies. Kisspeptin 10MG gives researchers a tool for studying reproductive health.

The product is available as a lyophilized powder, which improves stability and shelf life. Before testing, researchers should reconstitute the powder with bacteriostatic water. Each batch adheres to pharmaceutical-grade standards, providing purity, quality, and reliable results.

Please note: Kisspeptin 10MG is for research purposes only; it is not intended for human use and should be handled by trained personnel in a safe laboratory setting.

With its stability and pharmaceutical-grade quality, Kisspeptin offers scientists a stable tool for studies in reproduction, hormone health, and peptide science.

Kisspeptin-10 stimulates the release of gonadotropin-releasing hormone.

Kisspeptin-10, which comes from the kisspeptin protein, has become a focus in research because it helps release gonadotropin-releasing hormone (GnRH). GnRH is very important for sexual development and reproduction.

Studies suggest kisspeptin-10 can directly encourage GnRH release at nerve endings. This shows kisspeptin-10 has a new method of action, which could lead to new therapies.

In Females, sex steroids appear to regulate kisspeptin-10’s stimulation of gonadotropin secretion by feedback. This could change how we view hormonal balance and women’s reproductive health.

Boosting Testosterone

Kisspeptin-10 is a strong luteinizing hormone (LH) stimulator that can raise LH pulse frequency. Studies show that Kisspeptin-10 doses can greatly cause LH secretion in men. Ongoing administration of Kisspeptin-10 can increase testosterone levels, LH pulse frequency, and size.

Studies also indicate that giving Kisspeptin-10 can raise LH pulse frequency and secretion in men with type 2 diabetes who have low testosterone, giving proof of this idea.

In teens in their late stages of puberty, Kisspeptin-10 was found to greatly increase LH and testosterone levels in plasma.

Interestingly, Kisspeptin-10 also has a few possible benefits outside of hormone regulation. These include more sexual arousal, better mood and behavior, and fertility regulation.

This peptide is also suggested as a helpful addition to testosterone replacement therapy to keep fertility up and prevent testicle shrinkage.

Energy Balance

Kisspeptin-10 is important for keeping energy levels steady.

Studies show that kisspeptin neurons help manage energy balance, probably linking it to reproductive functions.

Animal studies indicate that kisspeptin signals control things like body weight and energy. So, kisspeptin-10 might directly keep energy in check.

Energy balance is closely tied to reproduction. Hypothalamic kisspeptin is believed to help manage these energy levels. Problems with energy balance often cause fertility issues, like hypothalamic hypogonadism.

Some studies suggest that brain-derived neurotrophic factor (BDNF) might be a key player in how melanocortin-4 receptor signals manage energy balance, and kisspeptin-10 could be part of this.

Evidence suggests that hormones like ghrelin and PYY3-36, together with the central neuropeptide kisspeptin, are new contributors in the neuroendocrine networks that balance energy.

Cancer studies

Research suggests that kisspeptins are involved in cancer growth and spread. They often show up in high amounts in tumors, like those in the breast, ovaries, and prostate. Also, kisspeptin signals can stop cancer cells from moving and invading other tissues, hinting at a possible treatment use.

For breast cancer, kisspeptin-10 can stop breast cancer cells from moving and invading. It does this by changing certain molecular routes that help cancer grow.

Kisspeptin-10 has also shown anti-spread action in melanoma, another cancer type. It can reduce melanoma cell invasion and movement, suggesting it could be used to treat melanoma.

While these results look good, more work is needed to fully understand how kisspeptin-10 works in cancer and to create good treatment plans.

Memory improvement research

Some studies suggest a potential relation between kisspeptin and cognitive functions. For example, a rat study showed that giving kisspeptin into the brain improved memory retention. The exact way this happens isn’t clear, but it might involve changing nerve cell activity.

It’s also possible that kisspeptin affects brain areas related to mood and thinking, like the hippocampus and amygdala. Still, the evidence isn’t direct, and more work is needed to know for sure if there’s a strong relation between kisspeptin, specifically kisspeptin-10, and better memory.

Mood impact

Recent studies looked into how kisspeptin-10 might change mood and emotional regulation. Studies show that giving kisspeptin can change how the human brain connects, which makes sexual and emotional actions better. It was found to change both good and bad feelings and emotions.

Another study found that giving kisspeptin was linked to gentler bad moods. But the study didn’t find any changes in other hormones that could impact limbic activity.

The literature shows that kisspeptin signals are becoming more important for behavior, emotions, and awareness. This means that kisspeptin-10 might have a role in these actions, but more studies are needed to know for sure.

Kisspeptin has also been shown to have effects like antidepressants and impacts fear, which means it could play a role in how emotions are handled.

A food intake study suggests that kisspeptin might mediate the relationship between sex, emotions, and reproduction.

Kidneys and Heart

Although kisspeptin is usually linked to reproduction, studies suggest it impacts the kidneys. Kisspeptin and its receptors (Kiss1R) exist in different parts of kidney tissue and likely participate in signaling that controls how the kidneys work. Tests on mice lacking the Kiss1 receptor support kisspeptin’s role in normal kidney development; without it, glomeruli development might be impaired. It’s not yet clear if it acts by itself or if these results come from other hormones and growth factors, but the peptide’s importance to the kidneys is clear.

Kisspeptin-10 seems to control not just reproductive processes and kidney function, but also the cardiovascular system. Studies on mice with cardiovascular issues show that kisspeptin might selectively affect different vascular areas. It can control vasoconstriction and, in some situations, even change cardiac output. These results are thought to be mostly connected to kisspeptin’s ability to stimulate or stop angiogenesis—the process of creating new blood vessels. This mechanism also helps explain the peptide’s anti-cancer activity: by controlling the vascular system, kisspeptin might lower the chance of metastasis.

This article was checked, edited, and organized by Dr. E. Logan, M.D. Dr. Logan has a Doctor of Medicine degree from Case Western Reserve University School of Medicine and a Bachelor of Science degree in Molecular Biology. This translation was provided by peptolabs.com.

List of links:

1. W. S. Dhillo et al., “Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males,” J. Clin. Endocrinol. Metab., vol. 90, no. 12, pp. 6609–6615, Dec. 2005, doi: 10.1210/jc.2005-1468.
2. J. T. George et al., “Kisspeptin-10 is a potent stimulator of LH and increases pulse frequency in men,” J. Clin. Endocrinol. Metab., vol. 96, no. 8, pp. E1228-1236, Aug. 2011, doi: 10.1210/jc.2011-0089.
3. C. J. L. Harter, G. S. Kavanagh, and J. T. Smith, “The role of kisspeptin neurons in reproduction and metabolism,” J. Endocrinol., vol. 238, no. 3, pp. R173–R183, 2018, doi: 10.1530/JOE-18-0108.
4. E. J. Mead, J. J. Maguire, R. E. Kuc, and A. P. Davenport, “Kisspeptins: a multifunctional peptide system with a role in reproduction, cancer and the cardiovascular system,” Br. J. Pharmacol., vol. 151, no. 8, pp. 1143–1153, Aug. 2007, doi: 10.1038/sj.bjp.0707295.
5. T. Ly, S. Harihar, and D. R. Welch, “KISS1 in metastatic cancer research and treatment: potential and paradoxes,” Cancer Metastasis Rev., Mar. 2020, doi: 10.1007/s10555-020-09868-9.
6. P. Pazarci et al., “The effects of daylight exposure on melatonin levels, Kiss1 expression, and melanoma formation in mice,” Croat. Med. J., vol. 61, no. 1, pp. 55–61, Feb. 2020.
7. E. Gibula-Tarlowska and J. H. Kotlinska, “Kissorphin improves spatial memory and cognitive flexibility impairment induced by ethanol treatment in the Barnes maze task in rats,” Behav. Pharmacol., vol. 31, no. 2 & 3, pp. 272–282, Apr. 2020, doi: 10.1097/FBP.0000000000000557.
8. A. N. Comninos et al., “Kisspeptin modulates sexual and emotional brain processing in humans,” J. Clin. Invest., vol. 127, no. 2, pp. 709–719, doi: 10.1172/JCI89519.
9. M. Bhattacharya and A. V. Babwah, “Kisspeptin: Beyond the Brain,” Endocrinology, vol. 156, no. 4, pp. 1218–1227, Apr. 2015, doi: 10.1210/en.2014-1915.
10. Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells. PubMed Central (PMC). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922395/